Brought to you by 
Viela Bio goes public, nets $160.5mm
25 Mar 2021
Executive Summary
Viela Bio Inc. (developing treatments for autoimmune and severe inflammatory diseases) netted $160.5mm in its initial public offering of 9.1mm common shares (including the overallotment) at $19. The company originally filed to sell 7.5mm shares at a range of $19-21.
Deal Industry
- Pharmaceuticals
-
Biotechnology
-
Large Molecule
- Antibodies
-
Large Molecule
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Viela Bio goes public, nets $160.5mm
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice